Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 24302815)

1.

Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.

De Paepe B, De Bleecker JL.

Mediators Inflamm. 2013;2013:540370. doi: 10.1155/2013/540370. Epub 2013 Nov 5. Review.

2.

Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis.

De Paepe B, Creus KK, Martin JJ, De Bleecker JL.

Muscle Nerve. 2012 Dec;46(6):917-25. doi: 10.1002/mus.23481.

PMID:
23225384
3.

Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy.

Passerini L, Bernasconi P, Baggi F, Confalonieri P, Cozzi F, Cornelio F, Mantegazza R.

Neuromuscul Disord. 2002 Nov;12(9):828-35.

PMID:
12398833
4.

An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease.

Girn HR, Orsi NM, Homer-Vanniasinkam S.

Vasc Med. 2007 Nov;12(4):299-309. Review.

PMID:
18048466
5.

Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Evans NP, Misyak SA, Robertson JL, Bassaganya-Riera J, Grange RW.

PM R. 2009 Aug;1(8):755-68. doi: 10.1016/j.pmrj.2009.04.010. Review.

7.

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.

Weir AP, Morgan JE, Davies KE.

Neuromuscul Disord. 2004 Jan;14(1):19-23.

PMID:
14659408
8.

Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm.

Demoule A, Divangahi M, Danialou G, Gvozdic D, Larkin G, Bao W, Petrof BJ.

Am J Respir Cell Mol Biol. 2005 Aug;33(2):178-85. Epub 2005 Apr 28.

PMID:
15860797
9.

Bone tissue and muscle dystrophin deficiency in mdx mice.

Nakagaki WR, Camilli JA.

Joint Bone Spine. 2012 Mar;79(2):129-33. doi: 10.1016/j.jbspin.2011.08.004. Epub 2011 Nov 12. Review. Erratum in: Joint Bone Spine. 2013 Oct;80(5):557-8.

PMID:
22079415
10.

Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice.

Jørgensen LH, Jensen CH, Wewer UM, Schrøder HD.

Am J Pathol. 2007 Nov;171(5):1599-607.

11.

Approaching a new age in Duchenne muscular dystrophy treatment.

Wagner KR.

Neurotherapeutics. 2008 Oct;5(4):583-91. doi: 10.1016/j.nurt.2008.08.013. Review.

PMID:
19019310
12.

Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy.

De Pasquale L, D'Amico A, Verardo M, Petrini S, Bertini E, De Benedetti F.

Neurology. 2012 Apr 24;78(17):1309-14. doi: 10.1212/WNL.0b013e3182518302. Epub 2012 Apr 11.

13.

Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).

Fukushima K, Nakamura A, Ueda H, Yuasa K, Yoshida K, Takeda S, Ikeda S.

BMC Musculoskelet Disord. 2007 Jun 28;8:54.

14.

Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.

Matsakas A, Yadav V, Lorca S, Narkar V.

FASEB J. 2013 Oct;27(10):4004-16. doi: 10.1096/fj.13-228296. Epub 2013 Jun 18.

15.

Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.

Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, Lamon S, Russell AP, Davies KE, Febbraio MA, Lynch GS.

Nature. 2012 Apr 4;484(7394):394-8. doi: 10.1038/nature10980.

PMID:
22495301
16.

Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.

Gordon BS, Delgado Díaz DC, Kostek MC.

Clin Nutr. 2013 Feb;32(1):104-11. doi: 10.1016/j.clnu.2012.06.003. Epub 2012 Jul 12.

PMID:
22795790
17.

Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species.

Whitehead NP, Yeung EW, Allen DG.

Clin Exp Pharmacol Physiol. 2006 Jul;33(7):657-62. Review.

PMID:
16789936
18.

Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.

Guerron AD, Rawat R, Sali A, Spurney CF, Pistilli E, Cha HJ, Pandey GS, Gernapudi R, Francia D, Farajian V, Escolar DM, Bossi L, Becker M, Zerr P, de la Porte S, Gordish-Dressman H, Partridge T, Hoffman EP, Nagaraju K.

PLoS One. 2010 Jun 21;5(6):e11220. doi: 10.1371/journal.pone.0011220.

19.

Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy.

Evans NP, Misyak SA, Robertson JL, Bassaganya-Riera J, Grange RW.

Am J Phys Med Rehabil. 2009 Jun;88(6):502-22. doi: 10.1097/PHM.0b013e3181a5a24f. Review.

PMID:
19454857
20.

Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.

Ahmad A, Brinson M, Hodges BL, Chamberlain JS, Amalfitano A.

Hum Mol Genet. 2000 Oct 12;9(17):2507-15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk